Recent Price Movement and Market Context
On 24 Nov 2025, Hikal’s stock touched an intraday low of Rs.219.55, representing a fall of 2.47% on the day. This decline extends a two-day losing streak, during which the stock has recorded a cumulative return of -3.72%. The day’s performance also saw Hikal underperform its sector by 2.06%, reflecting broader challenges within its segment.
Notably, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum. This contrasts with the broader market, where the Sensex opened 88.12 points higher and was trading at 85,369.96, up 0.16%. The Sensex remains close to its 52-week high of 85,801.70 and has been on a three-week consecutive rise, gaining 2.59% in that period. Mid-cap stocks are also leading gains, with the BSE Mid Cap index up by 0.21% on the same day.
Long-Term Price Performance
Over the past year, Hikal’s stock has declined by 43.51%, a stark contrast to the Sensex’s positive return of 7.92% over the same period. The stock’s 52-week high was Rs.464.50, indicating a near 53% reduction from that peak. This underperformance extends beyond the last year, with the stock lagging behind the BSE500 index over the last three years, one year, and three months.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Financial Metrics Highlighting Current Concerns
Hikal’s financial indicators reveal pressures on profitability and operational efficiency. The company’s operating profits have shown a compound annual growth rate (CAGR) of -16.24% over the last five years, indicating a contraction in earnings before interest, taxes, depreciation, and amortisation. This trend is compounded by a high Debt to EBITDA ratio of 2.51 times, suggesting limited capacity to comfortably service debt obligations.
Return on Equity (ROE) averaged 8.00%, reflecting modest profitability relative to shareholders’ funds. The company’s recent quarterly results have been notably weak, with earnings per share (EPS) falling by 320.54%, and a net loss after tax (PAT) of Rs. -34.90 crores reported in the latest quarter. This represents a significant decline compared to the previous four-quarter average.
Return on Capital Employed (ROCE) for the half-year period stands at 4.44%, one of the lowest levels recorded, while the operating profit to interest coverage ratio has dropped to 0.48 times, indicating tight margins for meeting interest expenses.
Valuation and Comparative Positioning
Despite the subdued financial performance, Hikal’s valuation metrics suggest it is trading at a discount relative to its peers. The company’s ROCE of 4.1 and an enterprise value to capital employed ratio of 1.8 indicate an attractive valuation on a relative basis. However, this valuation reflects the market’s assessment of the company’s current challenges and subdued profit generation, with profits falling by 86.2% over the past year.
Majority ownership remains with the promoters, maintaining a stable shareholding structure amid the stock’s price volatility.
Why settle for Hikal ? SwitchER evaluates this Pharmaceuticals & Biotechnology small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Market and Stock Dynamics
While the broader market indices, including the Sensex and mid-cap segments, have demonstrated resilience and upward momentum, Hikal’s stock continues to face downward pressure. The stock’s fall to Rs.219.55 marks a significant technical milestone, reflecting ongoing challenges in profitability, debt servicing, and investor sentiment.
The divergence between Hikal’s performance and the broader market underscores sector-specific and company-specific factors influencing its valuation and price trajectory. The stock’s position below all major moving averages further emphasises the prevailing bearish trend in the near term.
Investors and market participants will continue to monitor Hikal’s financial disclosures and market developments to assess any shifts in its performance metrics and valuation dynamics.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
